University of Connecticut Develops Two Embryonic Stem Cell Lines

By David Goodhue  |  AHN  |  Link to article
January 29, 2009

Miami, FL (AHN) - The University of Connecticut has developed two lines of human embryonic stem cells.

The lines, named CT1 and CT2, are the results of the school's 10-year, $100-million commitment to stem cell research. They will be sold to researchers for a nominal fee to study their potential for medical use, according to the Connecticut Post.

The Bush administration placed restrictions on spending federal money on embryonic stem cell research, so Connecticut lawmakers approved state funding for projects at UCONN, Yale and Wesleyan.

The Obama administration is expected to lift the ban, and the Food and Drug Administration recently approved a trial on embryonic stem cell treatment for spinal cord injuries.

University of Connecticut researchers said medical breakthroughs using embryonic stem cells could be achieved within the next four years.